
Analysis of Protein Post-Translational Modifications by Mass Spectrometry
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
More details
Other editions
Additional editions


Persons
Richard Unwin is a biochemist and mass spectrometrist with over 18 years' experience in the field of proteomics, in particular the quantification and characterization of proteins by mass spectrometry. Richard was among the first to develop the use of iTRAQ technology for protein quantitation and, with John Griffiths, was also amongst the first researchers to begin to realize the potential of multiple reaction monitoring MS for the discovery and characterization of post-translational modifications. Richard has contributed chapters on proteomics methods for a number of textbooks, aimed at both practicing mass spectrometrists and undergraduates, and has authored over 40 papers in the field.
Content
List of Contributors xi
Preface xv
1 Introduction 1
Rebecca Pferdehirt, Florian Gnad and Jennie R. Lill
1.1 Post-translational Modification of Proteins 1
1.2 Global versus Targeted Analysis Strategies 3
1.3 Mass Spectrometric Analysis Methods for the Detection of PTMs 5
1.3.1 Data?-Dependent and Data?-Independent Analyses 6
1.3.2 Targeted Analyses 7
1.3.3 Multiple Reaction Monitoring 8
1.3.4 Multiple Reaction Monitoring Initiated Detection and Sequencing 9
1.4 The Importance of Bioinformatics 9
Acknowledgements 11
References 11
2 Identification and Analysis of Protein Phosphorylation by Mass Spectrometry 17
Dean E. McNulty, Timothy W. Sikorski and Roland S. Annan
2.1 Introduction to Protein Phosphorylation 17
2.2 Analysis of Protein Phosphorylation by Mass Spectrometry 25
2.3 Global Analysis of Protein Phosphorylation by Mass Spectrometry 39
2.4 Sample Preparation and Enrichment Strategies for Phosphoprotein Analysis by Mass Spectrometry 46
2.5 Multidimensional Separations for Deep Coverage of the Phosphoproteome 54
2.6 Computational and Bioinformatics Tools for Phosphoproteomics 57
2.7 Concluding Remarks 65
References 66
3 Analysis of Protein Glycosylation by Mass Spectrometry 89
David J. Harvey
3.1 Introduction 89
3.2 General Structures of Carbohydrates 89
3.2.1 Protein?-Linked Glycans 90
3.3 Isolation and Purification of Glycoproteins 94
3.3.1 Lectin Affinity Chromatography 95
3.3.2 Boronate?-Based Compounds 95
3.3.3 Hydrazide Enrichment 96
3.3.4 Titanium Dioxide Enrichment of Sialylated Glycoproteins 96
3.4 Mass Spectrometry of Intact Glycoproteins 96
3.5 Site Analysis 96
3.6 Glycan Release 98
3.6.1 Use of Hydrazine 99
3.6.2 Use of Reductive ß?-Elimination 99
3.6.3 Use of Enzymes 100
3.7 Analysis of Released Glycans 102
3.7.1 Cleanup of Glycan Samples 102
3.7.2 Derivatization 102
3.7.2.1 Derivatization at the Reducing Terminus 102
3.7.2.2 Derivatization of Hydroxyl Groups: Permethylation 104
3.7.2.3 Derivatization of Sialic Acids 106
3.7.3 Exoglycosidase Digestions 106
3.7.4 HPLC and ESI 107
3.8 Mass Spectrometry of Glycans 107
3.8.1 Aspects of Ionization for Mass Spectrometry Specific to the Analysis of Glycans 107
3.8.1.1 Electron Impact (EI) 107
3.8.1.2 Fast Atom Bombardment (FAB) 108
3.8.1.3 Matrix?-Assisted Laser Desorption/Ionization (MALDI) 108
3.8.1.4 Electrospray Ionization (ESI) 113
3.8.2 Glycan Composition by Mass Spectrometry 114
3.8.3 Fragmentation 114
3.8.3.1 Nomenclature of Fragment Ions 116
3.8.3.2 In?-Source Decay (ISD) Ions 116
3.8.3.3 Postsource Decay (PSD) Ions 117
3.8.3.4 Collision?-Induced Dissociation (CID) 117
3.8.3.5 Electron Transfer Dissociation (ETD) 118
3.8.3.6 Infrared Multiphoton Dissociation (IRMPD) 118
3.8.3.7 MSn 118
3.8.3.8 Fragmentation Modes of Different Ion Types 119
3.8.4 Ion Mobility 126
3.8.5 Quantitative Measurements 128
3.9 Computer Interpretation of MS Data 128
3.10 Total Glycomics Methods 130
3.11 Conclusions 131
Abbreviations 131
References 133
4 Protein Acetylation and Methylation 161
Caroline Evans
4.1 Overview of Protein Acetylation and Methylation 161
4.1.1 Protein Acetylation 161
4.1.2 Protein Methylation 162
4.1.3 Functional Aspects 163
4.1.4 Mass Spectrometry Analysis 163
4.2 Mass Spectrometry Behavior of Modified Peptides 164
4.2.1 MS Fragmentation Modes 164
4.2.2 Acetylation?- and Methylation?-Specific Diagnostic Ions in MS Analysis 165
4.2.3 Application of MS Methodologies for the Analysis of PTM Status 168
4.2.4 Quantification Strategies 169
4.2.4.1 Single Reaction Monitoring/Multiple Reaction Monitoring 170
4.2.4.2 Parallel Reaction Monitoring 171
4.2.4.3 Data?-Independent Acquisition MS 172
4.2.4.4 Ion Mobility MS 173
4.2.5 Use of Stable Isotope-Labeled Precursors 174
4.2.5.1 Dynamics of Acetylation and Methylation 174
4.2.5.2 Stoichiometry of Acetylation and Methylation 175
4.3 Global Analysis 176
4.3.1 Top?-Down Proteomics 176
4.3.2 Middle Down 177
4.4 Enrichment 178
4.4.1 Immunoaffinity Enrichment 178
4.4.2 Reader Domain?-Based Capture 179
4.4.2.1 Kac?-Specific Capture Reagents 179
4.4.2.2 Methyl?-Specific Capture Reagents 180
4.4.3 Biotin Switch?-Based Capture 180
4.4.4 Enrichment of N?-Terminally Acetylated Peptides 181
4.5 Bioinformatics 181
4.5.1 Assigning Acetylation and Methylation Status 182
4.5.2 PTM Repositories and Data Mining Tools 183
4.5.3 Computational Prediction Tools for Acetylation and Methylation Sites 183
4.5.4 Information for Design of Follow?-Up Experiments 185
4.6 Summary 185
References 185
5 Tyrosine Nitration 197
Xianquan Zhan, Ying Long and Dominic M. Desiderio
5.1 Overview of Tyrosine Nitration 197
5.2 MS Behavior of Nitrated Peptides 199
5.3 Global Analysis of Tyrosine Nitration 208
5.4 Enrichment Strategies 214
5.5 Concluding Remarks 221
Acknowledgements 222
Abbreviations 222
References 223
6 Mass Spectrometry Methods for the Analysis of Isopeptides Generated from Mammalian Protein Ubiquitination and SUMOylation 235
Navin Chicooree and Duncan L. Smith
6.1 Overview of Ub and SUMO 235
6.1.1 Biological Overview of Ubiquitin?-Like Proteins 235
6.1.2 Biological Overview of Ub and SUMO 236
6.1.3 Biological Functions of Ub and SUMO 236
6.2 Mass Spectrometry Behavior of Isopeptides 237
6.2.1 Terminology of a Ub/Ubl isopeptide 237
6.2.2 Mass Spectrometry Analysis of SUMO?-Isopeptides Derived from Proteolytic Digestion 238
6.2.3 Analysis of SUMO?-Isopeptides with Typical Full?-Length Tryptic Iso?-chains 238
6.2.4 Analysis of SUMO?-Isopeptides with Atypical Tryptic Iso?-chains and Shorter Iso?-chains Derived from Alternative Digestion Strategies 244
6.2.4.1 SUMO?-Isopeptides with Atypical Iso?-chains Generated from Tryptic Digestion 244
6.2.4.2 Dual Proteolytic Enzyme Digestion with Trypsin and Chymotrypsin 247
6.2.4.3 Proteolytic Enzyme and Chemical Digestion with Trypsin and Acid 248
6.2.5 MS Analysis of Modified Ub?- and SUMO?-Isopeptides under CID Conditions 250
6.2.6 SPITC Modification 251
6.2.7 Dimethyl Modification 252
6.2.8 m?-TRAQ Modification 256
6.3 Enrichment and Global Analysis of Isopeptides 259
6.3.1 Overview of Enrichment Approaches 259
6.3.2 K?-GG Antibody 260
6.3.3 COFRADIC 262
6.3.4 SUMOylation Enrichment 263
6.4 Concluding Remarks and Recommendations 265
References 267
7 The Deimination of Arginine to Citrulline 275
Andrew J. Creese and Helen J. Cooper
7.1 Overview of Arginine to Citrulline Conversion: Biological Importance 275
7.2 Mass Spectrometry?-Based Proteomics 279
7.3 Liquid Chromatography and Mass Spectrometry Behavior of Citrullinated Peptides 283
7.4 Global Analysis of Citrullination 288
7.5 Enrichment Strategies 291
7.6 Bioinformatics 296
7.7 Concluding Remarks 297
Acknowledgements 297
References 297
8 Glycation of Proteins 307
Naila Rabbani and Paul J. Thornalley
8.1 Overview of Protein Glycation 307
8.2 Mass Spectrometry Behavior of Glycated Peptides 315
8.3 Global Analysis of Glycation 318
8.4 Enrichment Strategies 319
8.5 Bioinformatics 320
8.6 Concluding Remarks 323
Acknowledgements 324
References 324
9 Biological Significance and Analysis of Tyrosine Sulfation 333
Éva Klement, Éva Hunyadi-Gulyás and Katalin F. Medzihradszky
9.1 Overview of Protein Sulfation 333
9.2 Mass Spectrometry Behavior of Sulfated Peptides 334
9.3 Enrichment Strategies and Global Analysis of Sulfation 340
9.4 Sulfation Site Predictions 342
9.5 Summary 343
Acknowledgements 344
References 344
10 The Application of Mass Spectrometry for the Characterization of Monoclonal Antibody-Based Therapeutics 351
Rosie Upton, Kamila J. Pacholarz, David Firth, Sian Estdale and Perdita E. Barran
10.1 Introduction 351
10.1.1 Antibody Structure 352
10.1.2 N-Linked Glycosylation 354
10.1.3 Antibody-Drug Conjugates 355
10.1.4 Biosimilars 356
10.2 Mass Spectrometry Solutions to Characterizing Monoclonal Antibodies 358
10.2.1 Hyphenated Mass Spectrometry (X-MS) Techniques to Study Glycosylation Profiles 359
10.2.2 Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS) to Characterize Monoclonal Antibody Structure 361
10.2.3 Native Mass Spectrometry and the Use of IM-MS to Probe Monoclonal Antibody Structure 365
10.3 Advanced Applications 369
10.3.1 Quantifying Glycosylation 369
10.3.2 Antibody-Drug Conjugates 370
10.3.3 Biosimilar Characterization 372
10.4 Concluding Remarks 374
References 374
Index 387
Chapter 1
Introduction
Rebecca Pferdehirt, Florian Gnad and Jennie R. Lill
Proteomics and Biological Resources, Genentech Inc., South San Francisco, CA, USA
1.1 Post-translational Modification of Proteins
While the human proteome is encoded by approximately 20,000 genes [1, 2], the functional diversity of the proteome is orders of magnitude larger because of added complexities such as genomic recombination, alternative transcript splicing, or post-translational modifications (PTMs) [3, 4]. PTMs include the proteolytic processing of a protein or the covalent attachment of a chemical or proteinaceous moiety to a protein allowing greater structural and regulatory diversity. Importantly, PTMs allow for rapid modification of a protein in response to a stimulus, resulting in functional flexibility on a timescale that traditional transcription and translation responses could never accommodate. PTMs range from global modifications such as phosphorylation, methylation, ubiquitination, and glycosylation, which are found in all eukaryotic species in all organs, to more specific modifications such as crotonylation (thought to be spermatozoa specific) and hypusinylation (specific for EIF5a), which govern more tight regulation of associated proteins. Taken together, over 200 different types of PTMs have been described [5], resulting in an incredibly complex repertoire of modified proteins throughout the cell.
The addition and subtraction of PTMs are controlled by tight enzymatic regulation. For example, many proteins are covalently modified by the addition of a phosphate group onto tyrosine, serine, or threonine residues in a process called phosphorylation [6]. Phosphorylation is catalyzed by a diverse class of enzymes called kinases [7], whereas these phosphomoieties are removed by a second class of enzymes referred to as phosphatases. The tight regulation of kinases and phosphatases often creates "on/off" switches essential for regulation of sensitive signaling cascades. There are some exceptions to this rule however, and the hunt is still underway for the ever-elusive hypusine [8] removing enzyme or putative enzymes responsible for the removal of protein arginine methylation. However, it is also possible that proteins bearing these PTMs are modulated or removed from the cell by other mechanisms of action. For example, proteolysis is rarely (if ever) reversible, and many proteins (e.g., blood clotting factors and digestive enzymes) are tightly governed by irreversible cleavage events where the active form is created after proteolysis of a proenzyme.
While PTMs such as phosphorylation and lysine acetylation exist in a binary "on/off" state, many other PTMs exhibit much more complex possible modification patterns. For example, lysine residues can be modified by covalent attachment of the small protein ubiquitin, either by addition of a single ubiquitin or by addition of ubiquitin polymers. In the latter case ubiquitin itself is used as the point of attachment for addition of subsequent ubiquitin monomers [9]. To add another layer of complexity, ubiquitin has seven lysines (K6, K11, K27, K29, K33, K48, and K63), each of which may be used as the point of polyubiquitin chain linkage, and each of which has a different functional consequence. For example, K63-linked chains are associated with lysosomal targeting, whereas K48-linked chains trigger substrate degradation by the proteasome. Thus, even within one type of PTM, multiple subtypes exist, further expanding the functional possibilities of protein modification.
In addition, many proteins are modified on multiple residues by different types of PTMs. A classic example is the PTM of histones. Histones are nuclear proteins that package and compact eukaryotic DNA into structural units called nucleosomes, which are the basic building blocks of chromatin and essential for regulation of gene expression. The C-termini of histones are composed of unstructured tails that protrude from nucleosomes and are heavily modified by methylation, acetylation, ubiquitylation, phosphorylation, SUMOylation, and other PTMs [10]. Overall, 26 modified residues on a single-core histone have been identified, and many of these residues can harbor multiple PTM types. In a generally accepted theory referred to as the "histone code," the combination of PTMs on all histones comprising a single nucleosome or group of nucleosomes regulates fine-tuned expression of nearby genes.
As we begin to uncover the modified proteome, the importance of the interplay between multiple different PTMs has become increasingly apparent. One classic example is the involvement of both protein phosphorylation and ubiquitylation in the regulation of signaling networks [11]. Protein phosphorylation commonly promotes subsequent ubiquitylation, and the activities of ubiquitin ligases are also frequently regulated through phosphorylation. In a recent study by Ordureau et al., quantitative proteomic studies were employed to describe the PINK1 kinase-PARKIN UB ligase pathway and its disruption in Parkinson's disease [12]. The authors describe a feedforward mechanism where phosphorylation of PARKIN by PINK1 occurs upon mitochondrial damage, leading to ubiquitylation of mitochondria and mitochondrial proteins by PARKIN. These newly formed ubiquitin chains are then themselves phosphorylated by PINK1, which promotes association of phosphorylated PARKIN with polyubiquitin chains on the mitochondria, and ultimately results in signal amplification. This model exemplifies how intricate interactions between multiple different PTMs regulate protein localization, interactions, activity, and ultimately essential cellular processes.
Recent advances in mass spectrometry methods, instrumentation, and bioinformatics analyses have enabled the identification and quantification of proteome-wide PTMs. For example, it is now a common practice to identify ten thousand phosphorylation sites in a single phosphoproteome enrichment experiment [13]. In addition, precise quantitation allows a deeper understanding of the combinations and occupancy of PTMs within a given protein. Such MS-based PTM analyses have led to previously impossible discoveries, advancing our understanding of the role of PTMs in diverse biological processes.
1.2 Global versus Targeted Analysis Strategies
Detection of PTMs by mass spectrometry can be achieved via global or targeted methods. The biological pathway of interest usually determines the type of PTM to be analyzed and associated methods. In a more targeted approach, researchers decide to investigate PTMs, because a protein of interest shows a higher than expected molecular weight or multiple bands by western blot after application of a stimulus, thus prompting speculation as to whether this could be due to PTM. Either way, the first step in PTM mapping is to determine the type of PTM of interest. In some cases the observed mass shift in a mass spectrometer indicates a certain PTM type. Many PTMs, however, result in the same mass addition (e.g., +42 Da for both acetylation and trimethylation). One powerful strategy in determining PTM identity involves the employment of the enzymes responsible for PTM removal. For example, after antibody enrichment of a modified protein, the antibody-bound protein can be incubated with general phosphatases, deubiquitinating enzymes (DUBs), or deSUMOylating enzymes (SENPs), and PTM removal can be assayed by western blot. Another method for PTM identification is western blotting with PTM specific "pan-antibodies." Many commercially available antibodies exist for this purpose, recognizing common PTMs such as acetylation, methylation, ubiquitylation, and phosphorylation or even more rare PTMs such as crotonyl-, malonyl- or glutaryl-lysine modification. Once the type of PTM that is decorating a protein has been identified, the next step is to attempt to map the amino acid residue(s) that bear this modification.
One of the first applications of mass spectrometry in protein research was the mapping of a PTM on a single protein [14]. A commonly used approach involves protein-level immunoprecipitation followed by separating the captured proteins by SDS-PAGE, excising the higher molecular weight band, and performing in-gel tryptic digestion followed by LC-MS/MS. By searching for mass shifts indicative of the suspected modification(s), PTM-containing peptides can be identified and the PTM site mapped back to the protein. The strategy of identifying proteins in complex mixtures by digesting them into peptides, sequencing the resulting peptides by tandem mass spectrometry (MS/MS), and determining peptide and protein identity through automated database searching is referred to as shotgun proteomics and is one of the most popular analysis strategies in proteomics [15]. This protein-level enrichment approach, however, is dependent on sufficient levels of the modified protein compared to unmodified and the availability of protein-specific antibodies for immunoprecipitation. It is also possible that modifications may occur within the antibody epitope, blocking enrichment of the modified form altogether.
Researchers are commonly interested in analyzing PTMs from a complex mixture of proteins rather than on only one substrate. This can be a challenge, since modified peptides often occur in substoichiometric levels compared to unmodified versions and also may ionize less efficiently by electrospray ionization (ESI). However, several enrichment strategies exist, allowing for reduction of sample complexity and easier detection of the modified peptide species. Peptide-level immunoprecipitation using antibodies specific to a given...
System requirements
File format: ePUB
Copy protection: Adobe-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Install the free reader Adobe Digital Editions prior to download (see eBook Help).
- Tablet/smartphone (Android; iOS): Install the free app Adobe Digital Editions or the app PocketBook before downloading (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (not Kindle).
The file format ePub works well for novels and non-fiction books – i.e., „flowing” text without complex layout. On an e-reader or smartphone, line and page breaks automatically adjust to fit the small displays.
This eBook uses Adobe-DRM, a „hard” copy protection. If the necessary requirements are not met, unfortunately you will not be able to open the eBook. You will therefore need to prepare your reading hardware before downloading.
Please note: We strongly recommend that you authorise using your personal Adobe ID after installation of any reading software.
For more information, see our ebook Help page.